A review of the device history records (dhr) was performed for the indicated packaging and component lots for any deviations related to the reported defect of the complaint.The review confirms that the lots met all material, assembly and performance specifications.The june 2015 navilyst medical complaint report was reviewed for the bioflo picc family and the failure mode "leakage".No adverse trends were identified.The reported complaint description cannot be confirmed, nor can a definitive root cause for this incident be determined, as no sample was returned for eval.The dhr search revealed no quality related issues or mfg deficiencies at the time of mfr.Mfg process controls for the bioflo picc devices include visual inspection for damage or defects, various dimensional verifications and a tensile test of the molded luer-to-tube based on an aql.A 100% in process visual inspection for molding defects and a guidewire insertion test to verify lumen patency is required.In addition, al catheters are 100% sprint tested after the guidewire verification to ensure the catheter does not leak.(b)(4).
|